Ultromics
AI-powered software for cardiac ultrasound analysis and diagnosis.
About
Ultromics develops AI-driven software that analyzes cardiac ultrasound images to provide faster, more accurate diagnoses for heart conditions. Their platform aims to improve patient outcomes and reduce the burden on healthcare professionals by automating complex analysis tasks. Teams look it up for HealthTech, MedTech, AI-Driven Protein Design.
Frequently asked
What does Ultromics do?
Ultromics is a HealthTech company that offers Software. Teams look it up for MedTech, AI-Driven Protein Design, Clinical Trials. It is based in Oxford, United Kingdom and was founded in 2017. Public records show about 84 people and $103M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Ultromics raised?
Ultromics has raised a total of $103M in funding. The most recent round on record is Series C.
Where is Ultromics headquartered?
Ultromics is headquartered in Oxford, United Kingdom.
When was Ultromics founded?
Ultromics was founded in 2017.
What industry does Ultromics operate in?
Ultromics operates in HealthTech, MedTech, AI-Driven Protein Design, Clinical Trials, Digital Twin Healthcare.
How many employees does Ultromics have?
Ultromics has approximately 84 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.